EBay to Settle DOJ's Pill Press Probe for $59 Million
By Dean Seal
EBay will pay $59 million to settle the federal government's allegations that thousands of pill presses and encapsulating machines were sold on its popular online marketplace.
The Department of Justice said Wednesday that eBay has also agreed to enhance its compliance program in order to resolve claims that the pill press and encapsulating machine sales on its platform violated the Controlled Substances Act.
The government claims that hundreds of pill press buyers on eBay also purchased counterfeit molds, stamps or dies needed to produce pills that mimic the products of legitimate pharmaceutical companies. Many of those buyers have since been prosecuted in connection with trafficking illegal counterfeit pills, the DOJ said.
According to the settlement agreement, eBay denied the federal government's contention that it is subject to the Controlled Substances Act and doesn't admit liability in connection with the allegations.
A spokesperson for eBay didn't immediately respond to a request for comment.
The Justice Department is calling the agreement its fourth-largest Controlled Substances Act settlement ever and its first with an e-commerce company.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 31, 2024 10:53 ET (15:53 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks